Intracerebroventricular microinjection of the 5-HT 1F receptor agonist LY 344864 inhibits methamphetamine conditioned place preference reinstatement in rats

Relapse following a prolonged period of drug cessation is a key barrier in the treatment of methamphetamine (METH) addiction, for which pharmacological treatment exhibits little efficacy. Previous studies have suggested that this process involves alterations in levels of serotonin (5-HT) in the brai...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Pharmacology, biochemistry and behavior Ročník 173; s. 27
Hlavní autoři:	Shahidi, Siamak, Sadeghian, Reihaneh, Komaki, Alireza, Asl, Sara Soleimani
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 01.10.2018
Témata:	Amphetamine-Related Disorders - physiopathology Amphetamine-Related Disorders - psychology Animals Carbazoles - administration & dosage Carbazoles - pharmacology Central Nervous System Stimulants - pharmacology Conditioning, Classical - drug effects Dose-Response Relationship, Drug Fluorobenzenes - administration & dosage Fluorobenzenes - pharmacology Injections, Intraventricular Male Methamphetamine - pharmacology Rats Rats, Wistar Receptor, Serotonin, 5-HT1F Receptors, Serotonin - drug effects Recurrence Serotonin Receptor Agonists - pharmacology Relapse Conditioned place preference Serotonin receptor Methamphetamine
ISSN:	1873-5177
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!